PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-4110

  1. 550 Posts.
    lightbulb Created with Sketch. 225
    Bene are the supplier of the PPS for their cartrophen, so I am assuming they are supplying for these trials.
    I have asked the of Arthropharm, will let you know their response.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.